Clinical trial NCT05563324 - References

Self-Injurious Behavior — Genetics of Self-injurious Behaviour

Citation(s)

•   Bach P, Weil G, Pompili E, Hoffmann S, Hermann D, Vollstädt-Klein S, Mann K, Perez-Ramirez U, Moratal D, Canals S, Dursun SM, Greenshaw AJ, Kirsch P, Kiefer F, Sommer WH
  Incubation of neural alcohol cue reactivity after withdrawal and its blockade by naltrexone. Addict Biol. 2020 Jan;25(1):e12717. doi: 10.1111/adb.12717. Epub 2019 Feb 12.
•   Bunderla T, Kumperšcak HG
  Altered pain perception in self-injurious behavior and the association of psychological elements with pain perception measures: a systematic review. Psychiatr Danub. 2015 Dec;27(4):346-54.
•   Cao MQ, Hu SY, Zhang CH, Xia DS
  Study on the interrelationship between 5-HTTLPR/G-protein beta3 subunit (C825T) polymorphisms and depressive disorder. Psychiatr Genet. 2007 Aug;17(4):233-8.
•   Chanen AM, Jovev M, Djaja D, McDougall E, Yuen HP, Rawlings D, Jackson HJ
  Screening for borderline personality disorder in outpatient youth. J Pers Disord. 2008 Aug;22(4):353-64. doi: 10.1521/pedi.2008.22.4.353.
•   Chen D, Liu L, Xiao Y, Peng Y, Yang C, Wang Z
  Ethnic-specific meta-analyses of association between the OPRM1 A118G polymorphism and alcohol dependence among Asians and Caucasians. Drug Alcohol Depend. 2012 Jun 1;123(1-3):1-6. doi: 10.1016/j.drugalcdep.2011.10.012. Epub 2011 Nov 8. Review.
•   Chou WY, Yang LC, Lu HF, Ko JY, Wang CH, Lin SH, Lee TH, Concejero A, Hsu CJ
  Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty. Acta Anaesthesiol Scand. 2006 Aug;50(7):787-92.
•   Coller JK, Beardsley J, Bignold J, Li Y, Merg F, Sullivan T, Cox TC, Somogyi AA
  Lack of association between the A118G polymorphism of the mu opioid receptor gene (OPRM1) and opioid dependence: A meta-analysis. Pharmgenomics Pers Med. 2009;2:9-19. Epub 2009 Mar 20.
•   Comings DE, Rosenthal RJ, Lesieur HR, Rugle LJ, Muhleman D, Chiu C, Dietz G, Gade R
  A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics. 1996 Jun;6(3):223-34.
•   Eisenberg DT, Mackillop J, Modi M, Beauchemin J, Dang D, Lisman SA, Lum JK, Wilson DS
  Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study. Behav Brain Funct. 2007 Jan 10;3:2.
•   Eisenberger NI, Jarcho JM, Lieberman MD, Naliboff BD
  An experimental study of shared sensitivity to physical pain and social rejection. Pain. 2006 Dec 15;126(1-3):132-8. Epub 2006 Aug 4.
•   Eisenberger NI
  The neural bases of social pain: evidence for shared representations with physical pain. Psychosom Med. 2012 Feb-Mar;74(2):126-35. doi: 10.1097/PSY.0b013e3182464dd1. Epub 2012 Jan 27. Review.
•   Eisenberger NI
  Why rejection Hurts: What Social Neuroscience Has Revealed abaut the Brain's Response to Social rejection. Future Science: Essays from the Cutting Edge. 2011; 39: 586-598.
•   Gizatullin R, Zaboli G, Jönsson EG, Asberg M, Leopardi R
  Haplotype analysis reveals tryptophan hydroxylase (TPH) 1 gene variants associated with major depression. Biol Psychiatry. 2006 Feb 15;59(4):295-300. Epub 2005 Sep 13.
•   Grandy DK, Litt M, Allen L, Bunzow JR, Marchionni M, Makam H, Reed L, Magenis RE, Civelli O
  The human dopamine D2 receptor gene is located on chromosome 11 at q22-q23 and identifies a TaqI RFLP. Am J Hum Genet. 1989 Nov;45(5):778-85.
•   Haerian BS, Haerian MS
  OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis. Pharmacogenomics. 2013 May;14(7):813-24. doi: 10.2217/pgs.13.57. Review.
•   Jokela M, Räikkönen K, Lehtimäki T, Rontu R, Keltikangas-Järvinen L
  Tryptophan hydroxylase 1 gene (TPH1) moderates the influence of social support on depressive symptoms in adults. J Affect Disord. 2007 Jun;100(1-3):191-7. Epub 2006 Nov 28.
•   Joyce PR, McKenzie JM, Mulder RT, Luty SE, Sullivan PF, Miller AL, Kennedy MA
  Genetic, developmental and personality correlates of self-mutilation in depressed patients. Aust N Z J Psychiatry. 2006 Mar;40(3):225-9.
•   Kaess M, Hooley JM, Klimes-Dougan B, Koenig J, Plener PL, Reichl C, Robinson K, Schmahl C, Sicorello M, Westlund Schreiner M, Cullen KR
  Advancing a temporal framework for understanding the biology of nonsuicidal self- injury: An expert review. Neurosci Biobehav Rev. 2021 Nov;130:228-239. doi: 10.1016/j.neubiorev.2021.08.022. Epub 2021 Aug 24. Review.
•   Klepstad P, Rakvåg TT, Kaasa S, Holthe M, Dale O, Borchgrevink PC, Baar C, Vikan T, Krokan HE, Skorpen F
  The 118 A > G polymorphism in the human mu-opioid receptor gene may increase morphine requirements in patients with pain caused by malignant disease. Acta Anaesthesiol Scand. 2004 Nov;48(10):1232-9.
•   Koenig J, Thayer JF, Kaess M
  A meta-analysis on pain sensitivity in self-injury. Psychol Med. 2016 Jun;46(8):1597-612. doi: 10.1017/S0033291716000301. Epub 2016 Mar 11.
•   Koller G, Zill P, Rujescu D, Ridinger M, Pogarell O, Fehr C, Wodarz N, Bondy B, Soyka M, Preuss UW
  Possible association between OPRM1 genetic variance at the 118 locus and alcohol dependence in a large treatment sample: relationship to alcohol dependence symptoms. Alcohol Clin Exp Res. 2012 Jul;36(7):1230-6. doi: 10.1111/j.1530-0277.2011.01714.x. Epub 2012 Feb 6.
•   Lechner WV, Knopik VS, McGeary JE, Spillane NS, Tidey JW, McKee SA, Metrik J, Leventhal AM, Rohsenow DJ, Kahler CW
  Influence of the A118G Polymorphism of the OPRM1 Gene and Exon 3 VNTR Polymorphism of the DRD4 Gene on Cigarette Craving After Alcohol Administration. Nicotine Tob Res. 2016 May;18(5):632-6. doi: 10.1093/ntr/ntv136. Epub 2015 Jun 19.
•   Lee HJ, Cha JH, Ham BJ, Han CS, Kim YK, Lee SH, Ryu SH, Kang RH, Choi MJ, Lee MS
  Association between a G-protein beta 3 subunit gene polymorphism and the symptomatology and treatment responses of major depressive disorders. Pharmacogenomics J. 2004;4(1):29-33.
•   López-León S, Janssens AC, González-Zuloeta Ladd AM, Del-Favero J, Claes SJ, Oostra BA, van Duijn CM
  Meta-analyses of genetic studies on major depressive disorder. Mol Psychiatry. 2008 Aug;13(8):772-85. Epub 2007 Oct 16.
•   Matic M, de Wildt SN, Tibboel D, van Schaik RHN
  Analgesia and Opioids: A Pharmacogenetics Shortlist for Implementation in Clinical Practice. Clin Chem. 2017 Jul;63(7):1204-1213. doi: 10.1373/clinchem.2016.264986. Review.
•   McCloskey MS, Ben-Zeev D, Lee R, Berman ME, Coccaro EF
  Acute tryptophan depletion and self-injurious behavior in aggressive patients and healthy volunteers. Psychopharmacology (Berl). 2009 Mar;203(1):53-61. doi: 10.1007/s00213-008-1374-6. Epub 2008 Oct 23.
•   Nemoda Z, Lyons-Ruth K, Szekely A, Bertha E, Faludi G, Sasvari-Szekely M
  Association between dopaminergic polymorphisms and borderline personality traits among at-risk young adults and psychiatric inpatients. Behav Brain Funct. 2010 Jan 12;6:4. doi: 10.1186/1744-9081-6-4.
•   Neville MJ, Johnstone EC, Walton RT
  Identification and characterization of ANKK1: a novel kinase gene closely linked to DRD2 on chromosome band 11q23.1. Hum Mutat. 2004 Jun;23(6):540-5.
•   Ni X, Chan K, Bulgin N, Sicard T, Bismil R, McMain S, Kennedy JL
  Association between serotonin transporter gene and borderline personality disorder. J Psychiatr Res. 2006 Aug;40(5):448-53. Epub 2006 May 11.
•   Noble EP
  D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet. 2003 Jan 1;116B(1):103-25. Review.
•   Noblin JL, Venta A, Sharp C
  The validity of the MSI-BPD among inpatient adolescents. Assessment. 2014 Apr;21(2):210-7. doi: 10.1177/1073191112473177. Epub 2013 Jan 23.
•   Schinka JA, Town T, Abdullah L, Crawford FC, Ordorica PI, Francis E, Hughes P, Graves AB, Mortimer JA, Mullan M
  A functional polymorphism within the mu-opioid receptor gene and risk for abuse of alcohol and other substances. Mol Psychiatry. 2002;7(2):224-8.
•   Schwantes-An TH, Zhang J, Chen LS, Hartz SM, Culverhouse RC, Chen X, Coon H, Frank J, Kamens HM, Konte B, Kovanen L, Latvala A, Legrand LN, Maher BS, Melroy WE, Nelson EC, Reid MW, Robinson JD, Shen PH, Yang BZ, Andrews JA, Aveyard P, Beltcheva O, Brown SA, Cannon DS, Cichon S, Corley RP, Dahmen N, Degenhardt L, Foroud T, Gaebel W, Giegling I, Glatt SJ, Grucza RA, Hardin J, Hartmann AM, Heath AC, Herms S, Hodgkinson CA, Hoffmann P, Hops H, Huizinga D, Ising M, Johnson EO, Johnstone E, Kaneva RP, Kendler KS, Kiefer F, Kranzler HR, Krauter KS, Levran O, Lucae S, Lynskey MT, Maier W, Mann K, Martin NG, Mattheisen M, Montgomery GW, Müller-Myhsok B, Murphy MF, Neale MC, Nikolov MA, Nishita D, Nöthen MM, Nurnberger J, Partonen T, Pergadia ML, Reynolds M, Ridinger M, Rose RJ, Rouvinen-Lagerström N, Scherbaum N, Schmäl C, Soyka M, Stallings MC, Steffens M, Treutlein J, Tsuang M, Wall TL, Wodarz N, Yuferov V, Zill P, Bergen AW, Chen J, Cinciripini PM, Edenberg HJ, Ehringer MA, Ferrell RE, Gelernter J, Goldman D, Hewitt JK, Hopfer CJ, Iacono WG, Kaprio J, Kreek MJ, Kremensky IM, Madden PA, McGue M, Munafò MR, Philibert RA, Rietschel M, Roy A, Rujescu D, Saarikoski ST, Swan GE, Todorov AA, Vanyukov MM, Weiss RB, Bierut LJ, Saccone NL
  Association of the OPRM1 Variant rs1799971 (A118G) with Non-Specific Liability to Substance Dependence in a Collaborative de novo Meta-Analysis of European-Ancestry Cohorts. Behav Genet. 2016 Mar;46(2):151-69. doi: 10.1007/s10519-015-9737-3. Epub 2015 Sep 21.
•   Sloan ME, Klepp TD, Gowin JL, Swan JE, Sun H, Stangl BL, Ramchandani VA
  The OPRM1 A118G polymorphism: converging evidence against associations with alcohol sensitivity and consumption. Neuropsychopharmacology. 2018 Jun;43(7):1530-1538. doi: 10.1038/s41386-017-0002-8. Epub 2018 Feb 2.
•   Stanley B, Sher L, Wilson S, Ekman R, Huang YY, Mann JJ
  Non-suicidal self-injurious behavior, endogenous opioids and monoamine neurotransmitters. J Affect Disord. 2010 Jul;124(1-2):134-40. doi: 10.1016/j.jad.2009.10.028. Epub 2009 Nov 25.
•   van der Venne P, Balint A, Drews E, Parzer P, Resch F, Koenig J, Kaess M
  Pain sensitivity and plasma beta-endorphin in adolescent non-suicidal self-injury. J Affect Disord. 2021 Jan 1;278:199-208. doi: 10.1016/j.jad.2020.09.036. Epub 2020 Sep 11.
•   Victor SE, Glenn CR, Klonsky ED
  Is non-suicidal self-injury an "addiction"? A comparison of craving in substance use and non-suicidal self-injury. Psychiatry Res. 2012 May 15;197(1-2):73-7. doi: 10.1016/j.psychres.2011.12.011. Epub 2012 Mar 6.
•   Walter C, Doehring A, Oertel BG, Lötsch J
  µ-opioid receptor gene variant OPRM1 118 A>G: a summary of its molecular and clinical consequences for pain. Pharmacogenomics. 2013 Nov;14(15):1915-25. doi: 10.2217/pgs.13.187. Review.
•   Way BM, Taylor SE, Eisenberger NI
  Variation in the mu-opioid receptor gene (OPRM1) is associated with dispositional and neural sensitivity to social rejection. Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):15079-84. doi: 10.1073/pnas.0812612106. Epub 2009 Aug 14.
•   White MJ, Morris CP, Lawford BR, Young RM
  Behavioral phenotypes of impulsivity related to the ANKK1 gene are independent of an acute stressor. Behav Brain Funct. 2008 Nov 24;4:54. doi: 10.1186/1744-9081-4-54.
•   Woodcock EA, Lundahl LH, Burmeister M, Greenwald MK
  Functional mu opioid receptor polymorphism (OPRM1 A(118) G) associated with heroin use outcomes in Caucasian males: A pilot study. Am J Addict. 2015 Jun;24(4):329-35. doi: 10.1111/ajad.12187. Epub 2015 Apr 24.
•   Zaboli G, Gizatullin R, Nilsonne A, Wilczek A, Jönsson EG, Ahnemark E, Asberg M, Leopardi R
  Tryptophan hydroxylase-1 gene variants associate with a group of suicidal borderline women. Neuropsychopharmacology. 2006 Sep;31(9):1982-90. Epub 2006 Feb 22.

Genetics of Self-injurious Behaviour

Details for clinical trial NCT05563324